AUS
NZ
UK
CA
USA
IND
LiveTiles Limited, Cann Group Limited and Kidman Resources Limitedâs stocks have witnessed a significant price action in the past few months. Letâs have a closer look at these stocks.
LiveTiles Limited (ASX: LVT)
 LiveTiles Limited (ASX:LVT) is a global company which is providing transformative enterprise solutions and intelligent design, which reshape the way people interact with technology.
The company in its latest 1st half FY 19 results announcement has reported its annualised recurring revenue at $22.9 million as at 31 December 2018, translating to a whopping 232% raise on a year-on-year basis. In mid-November 2018, the company announced that the N3 sales and marketing team had generated a pipeline of sales opportunities for LiveTiles which more than $50 million. The company had strong growth in cash receipts which is up by 230% on prior corresponding period to $6.4 million for the half year.
On the price-performance front, the stock of LiveTiles Limited last traded flat at A$0.410 during the day's trade, with a market capitalisation of A$267.75 million. The stock has generated a YTD return of 22.06% and posted returns of 24.24% and 10.81% over the last three months and one-month period respectively. It has a 52-week high price of $0.755 and a 52-week low price of A$0.275. The robust financial performance on pcp basis has made the stock look attractive coupled with its short-term price performance.
Cann Group Limited (ASX:CAN)
Cann Group Limited (ASX:CAN) is into the development of medical cannabis products which in turn can improve the quality of life for patients in Australia. The expertise of the company coupled with its partnerships, support the rapid growth of globally competitive Australian research, cultivation and production capabilities.
In February 2018, the company announced that it had received two new licences from the Office of Drug Control to enable the continuation of their cultivation and production of cannabis for research and medicinal purposes. The company has Internal R&D capabilities supplemented with key partnerships & collaborations. With the Australian pharma sector relying heavily on medicines based on cannabis, the company is placed in a robust position to derive advantage from the new licences. Moreover, it is seeking for a stage 3 expansion, which will involve a state-of-the-art greenfield development including glasshouse cultivation space, research and development laboratories and full GMP manufacturing facilities. Also, with MOU signed with Australian Pacific Airports Pty Ltd June 2018, the project is in the design phase, with commissioning of the initial works targeted in July 2019.
On the financial performance, front CAN reported a net outflow of operating cash flow of $2.20 million for the quarter ended 31-December 2018. However, the ending cash balance stood at $72.64 million for the quarter. On the price-performance front, the stock of Cann Group Limited last traded at A$1.700 with a decrease of ~2.578% during the dayâs trade, with a market capitalisation of A$243.8 million.
Kidman Resources Limited (ASX:KDR)
Kidman Resources Limited (ASX:KDR) is into lithium development, coupled with the development of the Tier-one globally significant Mt Holland Lithium Deposit in Western Australia through a Joint Venture with SQM.
The company has given a notice of change in the directorâs interest. The change has arisen as a result of Mr. Southam ceasing to be an employee of Western Areas Limited (Western Areas) with effect from 31 January 2019. Mr. Southam had an indirect interest in the securities held by Western Areas through his position as an Executive Director and employee of that company.
On the business operation front, the company is well progressed on its strategy of becoming a low-cost, integrated producer of lithium hydroxide for the growing electric vehicle market. It has a high-quality, globally significant resource located in the tier one mining jurisdiction of Western Australia. Moreover, it got SQM as a high-quality joint venture partner who provides significant support to project delivery. The company is funded to support the initial stages of project CapEx with offtake arrangements providing support for Kidmanâs ongoing bank financing discussions. With a robust fundamental the company has a positive outlook going forward.
On the financial performance front, the company reported an outflow of operating cash flow of $~5.26 million for the quarter ended 31-December 2018, with cash and cash equivalents standing at $30.86 million as compared to $7.98 million in the previous quarter.
On the price-performance front, Kidman Resources has generated a decent return over the short term with a YTD return of 17.05%. Currently, it is trading at A$1.250 with a market capitalisation of A$514.09 million and with a 52-week high price of A$2.480 and 52-week low price of A$0.825.
Disclaimer
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.
